Author + information
- Received June 20, 1989
- Revision received August 30, 1989
- Accepted September 6, 1989
- Published online March 1, 1990.
- Anne L. Taylor, MD, FACC∗,
- Paolo Golino, MD,
- Robin Eckels, AA,
- Patricia Pastor, MA,
- L. Maximilian Buja, MD, FACC and
- James T. Willerson, MD, FACC
- ↵∗Address for reprints: Anne L. Taylor, MD, Division of Cardiology, H8.116, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9034
Prolonged depression of segmental systolic thickening after brief coronary artery occlusion may result principally from events during reperfusion rather than during the ischemic interval. Thus, cellular calcium overload at reperfusion may be a mediator of contractile dysfunction after brief ischemia, and reduction of calcium entry by diltiazem, a calcium channel antagonist, may enhance recovery of systolic thickening after brief periods of ischemia.
Thirteen awake unsedated dogs instrumented with hemodynamic catheters, left anterior descending coronary artery occluders and five to six pairs of intramyocardial sonomicrometers underwent two 15 min coronary artery occlusions with 24 h reperfusion. The order of infusion of diltiazem (15 μg/kg per min) or saline solution was alternated. Systolic thickening, hemodynamic variables and regional myocardial blood flow were measured serially over 24 h. Despite equally severe ischemic dysfunction during coronary occlusion, diltiazem-treated segments with systolic thinning during ischemia recovered control segmental thickening significantly earlier than saline solution-treated segments (at 30 versus 180 min of reperfusion). Blood pressure was mildly decreased during diltiazem treatment; therefore, a second group of 10 dogs underwent a similar occlusion and reflow period during infusion of nitroprusside to lower mean arterial pressure equivalently. Decreases in blood pressure in this group resulted in some improvement in segmental systolic function; however, this did not reach statistical significance at any time. Regional myocardial blood flows were similar in the saline solution-and diltiazem-treated groups during ischemia and reflow.
Thus, it is concluded that 1) diltiazem infusion significantly enhanced recovery of segmental systolic thickening after 15 min of ischemia and 24 h of reperfusion; 2) the enhancement in segmental systolic function could not entirely be attributed to decreased mean arterial pressure; 3) improvement in postischemic segmental ventricular function was seen only in those segments with systolic thinning during ischemia; thus, segments with the most severe ischemic dysfunction benefited most; and 4) there were no important differences in regional myocardial blood flow during ischemia and reperfusion between saline- and diltiazem-treated animals.
☆ This study was supported in part by NIH Clinical Investigator Award HLO1545 (Dr. Taylor) from the National Institutes of Health, Bethesda, Maryland, NHLBI Ischemic SCOR HL17669 Award from the National Heart, Lung, and Blood Institute, Bethesda, Maryland and the Moss Heart Fund, Dallas, Texas
- Received June 20, 1989.
- Revision received August 30, 1989.
- Accepted September 6, 1989.